Business Type:Trading Company
As a high-tech enterprise invested by Nanjing CHICO Pharmaceutical Co., Ltd., Anqing CHICO Pharmaceutical Co., Ltd is mainly engaged in the MAH/CDMO service of APIs and production of high-end pharmaceutical intermediates. Since inception, we have devoted ourselves to the research, development and production of small molecule targeted anti-tumor, anti-diabetic, anti-virus APIs and pharmaceutical intermediates. Our company is located in Anqing High-tech Industrial Development Zone (a province...
MoreTime of verification: | 2024-2-23 15:36 | |
Company Name: | ANQING CHICO PHARMACEUTICAL CO.,LTD. | |
Country/Territory: | China (Mainland) | |
Registered Address: | No. 8 Weiyi Road, Anqing High-tech Industrial Development Zon | |
Company Scale: |
51 - 100 | |
Registered Capital: |
12500000 |
|
Business Type: |
True |
|
Business Scope: |
By the end of 2018, through 10 years of continuous research and development, we have successfully developed : Small molecule targeted anti-tumor products: 21 projects ,such as Gefitinib, Erlotinib, Pazopanib, Lapatinib, Afatinib, Lenvatinib,etc; Diabetes products: 16 items ,such as Sitagliptin, Linagliptin,Alogliptin, Dapagliflozin, and Canagliflozin,etc; Anti-Cardiovascular products: 7 projects ,including Apixaban, Rivaroxaban, Betrixaban, and Dofetilide; |
|
Main Markets: |
North America South America Eastern Europe Southeast Asia Africa Oceania Mid East Eastern Asia Western Europe |
|
Company Corporate Representative: | David Wu |
Business License: |
|
Tax Registration Certificate: |
|
Organization Code Certificate: |
|
Legal person's id card: |